Scientists have developed an experimental way to study how human embryos implant in a uterus, which may provide new insights into why miscarriages occur and how they can be prevented.
An experimental gene therapy seems to slow the progression of Huntington’s disease by about 75 per cent, and researchers are ...
Zacks Small Cap Research on MSN

DYAI: Layers of commercialization agreements

The new arrangements were all announced in December and include a development and commercialization agreement signed with BRIG BIO, a commercial partnership with Opes Diagnostics and an expansion of ...
Now, Musunuru and colleagues are preparing a master clinical protocol to study a CRISPR therapy that's mostly the same as the one they used to treat baby KJ, except they plan to swap out the gene ...
Researchers have used CRISPR to switch back on a gene that vanished from the human lineage roughly 20 million years ago, reviving a natural defense against excess uric acid that our ancestors once ...
Scientists are using CRISPR to fast-track the domestication of a wild fruit. For roughly 10,000 years, farming communities ...
The code of life is now editable and the question humanity must answer in the 2020s is not whether we can rewrite it—but whether we should, and for whom.
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...
In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and triglycerides in people with difficult-to-treat lipid disorders, ...
CRISPR gene editing has transitioned from a laboratory curiosity to a cornerstone of modern biotechnology, revolutionizing our approach to genetic diseases, including Charcot-Marie-Tooth (CMT) disease ...